Edit Symbol List
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with UTHR as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|5.77%||First Trust Amex Biotechnology Index Fund (FBT)||+21.32 (34.27%)|
|2.09%||Guggenheim S&P Midcap 400 Pure Growth ETF (RFG)||+14.81 (13.35%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Our key therapeutic products and product candidates include: º • º Prostacyclin Analogues. Prostacyclin analogues are stable synthetic forms of prostacyclin, an important molecule produced by the body that has powerful effects on blood vessel health and function. Our lead product is Remodulin® (treprostinil) Injection (Remodulin), which is administered subcutaneously (under the skin) or intravenously (in the vein) for the treatment of pulmonary arterial hypertension (PAH). The United States Food and Drug Administration (FDA) approved Remodulin in 2002 for subcutaneous administration. ... More ...
|Annual EPS Est:||$3.28|
|Quarterly EPS Est:||1.59|